CLINICAL TRIALS
Cannabis

Formulation

CLINICAL TRIALS

ANZCTR

STATUS

NanaBis (NanoCelle CBD/THC) The buccal administration of a Cannabis sativa L. extract as an adjunct to opioid analgesia for the management of intractable pain in patients diagnosed with advanced cancer: a safety, tolerability and exploratory end-point pilot study Pending Recruiting TBA
NanaBidial (NanoCelle CBD) Initial Application Study: A phase 0 open-label single group clinical trial to investigate the safety of a microdose of a nanocelle™ cannabis formulation administered oro-buccally to healthy adult volunteers. Progressed to… Pharmacokinetic Pilot Study: The buccal administration of a nanocelle™CBD only preparation to healthy volunteers: a safety, tolerability and pharmacokinetic exploratory pilot study. Recruting Closed
NanaBidial (NanoCelle CBD) A Phase IIa Randomised Placebo Controlled Adjunctive Antiemetic Therapy With a Cannabinoid Extract in Preventing Chemotherapy-induced Nausea and Vomiting in Patients With Cancer Receiving Moderately to Highly Emetogenic Chemotherapy ACTRN12615000414516 Recruiting TBA
Delivery Platform

Formulation

CLINICAL TRIALS

ANZCTR

STATUS

NanoCelle D3 Vitamin D3 Hormone Blood Level Absorption Study in Healthy Adult Volunteers ACTRN12616001027404 Recruiting Closed
NanoCelle B12 Vitamin B12 Blood Level Absorption Study in Healthy Adult Volunteers ACTRN12616001326482 Recruiting Closed
NanoCelle CoQ10 Coenzyme Q10 Absorption Studies in Healthy Adult Volunteers ACTRN12616001037493 Recruiting Closed
NanoCelle Insulin A Phase 0 Open-Labelled Clinical Trial to Investigate the Safety of a Micro-dose of Nanocelle Insulin Formulation Administered Oro-buccally in Healthy Adult Volunteers ACTRN12616001072404 Recruiting TBA
NanoStat (NanoCelle Atorvastatin) Initial Application Study: A phase 0 open-labeled clinical trial to investigate the safety of a micro-dose* of a nanocelle Atorvastatin formulation administered oro-bucally in healthy adult volunteers. Progressed to… Bioequivalence Phase I Study: A single dose, open label, balanced, randomised, two-treatment, two period, two sequence, two-way crossover pilot study comparing the pharmacokinetics of 1 x 8 mg atorvastatin oral spray (Medlab Clinical, Australia) with 1 x 20 mg Lipitor® tablet (Pfizer, Australia) in healthy subjects under fasting conditions. ACTRN12615001285549 Recruiting TBA
Metabolic

Formulation

CLINICAL TRIALS

ANZCTR

STATUS

T2Biotic The Effect of a Multi-strain Probiotic on Metabolic Biomarkers in Adults with Pre-diabetes and Recently Diagnosed with Type 2 Diabetes ACTRN12613001378718 Recruiting Closed
Depression

Formulation

CLINICAL TRIALS

ANZCTR

STATUS

NRGBiotic A randomised placebo controlled clinical trial investigating the role of orotic acid and probiotics for the management of depression ACTRN12617000419369 Recruiting
Magnesium Orotate [First Pilot] S-adenosyl-L-methionine [SAMe] as an adjuvant to antidepressant medication in the treatment of resistant depression with a high risk of relapse - Recruiting Closed
NRGBiotic [Second Pilot] A Phase I safety and exploratory end-point trial investigating the role of Probiotics and Magnesium Orotate [NRGBiotic] co-administered with Antidepressant Medications for the Management of Treatment Resistant Depression - Recruiting Closed
Contract for 3rd Parties

Formulation

CLINICAL TRIALS

ANZCTR

STATUS

Contract Clinical Study A Phase IIa Double-Blind Placebo Controlled Clinical Trial Investigating the Efficacy and Safety of Arborvitae Health and Wellbeing Supplement in Improving Blood Glucose Levels in Pre-Diabetes Participants ACTRN12615000233527 Recruiting
Contract Clinical Study A Motivational Electronic Intervention Study for Patients Diagnosed with Type 2 Diabetes Mellitus (T2DM) (not currently prescribed on insulin) ACTRN12615000224527 Recruiting Closed
Contract Clinical Study An Open Label Pilot Comparative Clinical Trial of Dehydroepiandrosterone (DHEA) Efficacy Administered as a Troche versus Oral Strips in Males with Adrenal Fatigue ACTRN12616001048471 Recruiting Closed